The methodology of calculation of sample size in "non-inferiority" comparative controlled clinical trials: a comparison of two proportions in parallel group
The absolute majority of clinical trials of generic drugs aimed to compare the therapeutic efficacy of the tested drug and the drug of an active control. It is necessary to estimate that the test drug is not less effective (or non-inferior) than the control drug. The designs of the aforementioned tr...
Saved in:
Main Authors: | A. A. Lyashenko (Author), M. S. Svishcheva (Author) |
---|---|
Format: | Book |
Published: |
Izdatelstvo OKI,
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statistical notes for clinical researchers: Sample size calculation 2. Comparison of two independent proportions
by: Hae-Young Kim
Published: (2016) -
Comparison of three sample size calculation methods for non-inferiority vaccine trials with multiple continuous co-primary endpoints
by: Jiaying Yang, et al.
Published: (2019) -
Statistical notes for clinical researchers: Sample size calculation 1. comparison of two independent sample means
by: Hae-Young Kim
Published: (2016) -
Calculating incidence rates and prevalence proportions: not as simple as it seems
by: Inge Spronk, et al.
Published: (2019) -
Do patient characteristics matter when calculating sample size for eczema clinical trials?
by: L. Howells, et al.
Published: (2021)